Different substrate specificities of plasma lecithin: cholesterol acyl transferase in fish eye disease and Tangier disease.
Esterification of plasma free cholesterol is mediated by lecithin:cholesterol acyl transferase (LCAT). The free cholesterol of plasma high density lipoproteins (HDL) is considered to be the preferred substrate for LCAT. It therefore appeared as a paradox that plasma cholesterol esterification, both in vivo and in vitro, is normal in fish eye disease and Tangier disease, two familial conditions with extremely low plasma HDL levels. Fish eye disease plasma, however, was shown to have LCAT activity primarily acting on combined very low (VLDL) and low (LDL) density lipoproteins, denominated beta-LCAT, while it lacked LCAT activity esterifying HDL cholesterol (alpha-LCAT). Here we show that Tangier plasma, in contrast, has both alpha- and beta-LCAT. Thus, in both fish eye and Tangier diseases it is beta-LCAT that explains the apparent normal plasma cholesterol esterification. We also show that Tangier plasma, having alpha-LCAT activity, normalizes the low cholesteryl ester content as well as the abnormally small size of fish eye disease HDL particles during incubation.
King Gustaf V Research Institute, Stockholm, Sweden.
L A
LA
Carlson
L
L
Holmquist
G
G
Assmann
D002784:Cholesterol / Q000097:blood; D003318:Corneal Opacity / Q000097:blood / Q000201:enzymology*; D004951:Esterification; D005260:Female; D006801:Humans; D007009:Hypolipoproteinemias / Q000201:enzymology*; D008055:Lipids / Q000097:blood; D008297:Male; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood*; D013631:Tangier Disease / Q000097:blood / Q000201:enzymology*; D014280:Triglycerides / Q000097:blood
D008055:Lipids; D014280:Triglycerides; D002784:Cholesterol; D007862:Phosphatidylcholine-Sterol O-Acyltransferase